LMS-04 study: A randomised, multicenter, phase III study comparing doxorubicin alone versus doxorubicin with trabectedin followed by trabectedin in non-progressive patients as first-line therapy, in patients with metastatic or unresectable leiomyosarcoma - A French Sarcoma Group study

被引:10
作者
Pautier, P. [1 ]
Italiano, A. [2 ]
Piperno-Neumann, S. [3 ]
Chevreau, C. M. [4 ]
Penel, N. [5 ]
Cupissol, D. [6 ]
Rouquette, P. Boudou [7 ]
Bertucci, F. [8 ]
Balleyguier, C. [9 ]
Lebrun-Ly, V. [10 ]
Blay, J-Y. [11 ]
Kalbacher, E. [12 ]
Delcambre, C. [13 ]
Bompas, E. [14 ]
Collard, O. [15 ]
Isambert, N. [16 ]
Guillemet, C. [17 ]
Rios, M. [18 ]
Sundqvist, M. [19 ]
Duffaud, F. [20 ]
机构
[1] Inst Gustave Roussy, Med Dept, Villejuif, France
[2] Inst Bergonie, Early Phase Trials Unit, Bordeaux, France
[3] Inst Curie, Med Dept, Paris, France
[4] Inst Univ Canc Toulouse Oncopole, Oncol Dept, Toulouse, Haute Garonne, France
[5] Ctr Oscar Lambret, Gen Oncol Dept, Lille, France
[6] Inst Canc Montpellier, Med Dept, Montpellier, France
[7] Hop Cochin, AP HP, Med Oncol Dept, Site Port Royal, Paris, France
[8] Inst Paoli Calmettes, Med Oncol Dept, Marseille, France
[9] Inst Gustave Roussy, Radiol Dept, Villejuif, France
[10] Ctr Hosp Univ, Med Oncol, Limoges, France
[11] Ctr Leon Berard, Med Dept, Lyon, France
[12] Hop Jean Minjoz, Med Dept, Besancon, France
[13] Ctr Francois Baclesse, Med Dept, Caen, France
[14] Inst Cancerol Ouest, Med Dept, Nantes, France
[15] Inst Cancerol Lucien Neuwirth, Med Dept, St Priest En Jarez, France
[16] CHU Poitiers, Med Oncol, Poitiers, France
[17] Ctr Henri Becquerel, Med Dept, Rouen, France
[18] Inst Cancerol Lorraine, Med, Vandoeuvre Les Nancy, France
[19] Gustave Roussy, Biostat & Epidemiol Dept, Canc Campus, Villejuif, France
[20] APHP Marseilles, Med Oncol, Marseilles, France
关键词
D O I
10.1016/j.annonc.2021.08.2139
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
LBA59
引用
收藏
页码:S1335 / S1336
页数:2
相关论文
empty
未找到相关数据